BEIJING--(BUSINESS WIRE)--Novo Holdings, a leading global life science investor, and KKR, a leading global investment firm, today announced the signing of definitive agreements under which Novo ...

The collaboration brings together the medical expertise of Thammasat University Hospital and the global healthcare innovation of Novo Nordisk, with a shared vision of delivering more than just disease ...

Endothelial dysfunction is a form of heart disease that impairs blood vessels from dilating. Endothelial cells are a thin membrane that lines the inner surface of blood vessels and helps regulate ...

For example, according to the NIH, if you have a complicated pregnancy, you’re more likely to develop heart disease later on — especially if you’re obese. But a new study out of Sweden finds that ...

Over 200 patients were dosed, and 365 enrolled in the Nex-Z MAGNITUDE trial, aiming for 765 by early 2027. Intellia plans BLA filing for NTLA-2002 in HAE by late 2026, with a U.S. launch targeted ...

This was a retrospective analysis of a cohort study from a prospective, nationwide registry between January 2017 and December 2020 in Japan, focusing on patients with ACS who underwent DCB or DES for ...

"We're looking at a window in the future, showing the early changes that may explain why smoking marijuana has been linked to later heart disease," Springer said. "It appears the act of smoking and ...

However, for some, these symptoms may indicate a more serious condition: transthyretin amyloid cardiomyopathy (ATTR-CM). This rare heart disease is often underdiagnosed, especially in Black ...

This leads the patient to have a host of issues in many parts of the body like: Heart ... Novo Nordisk to develop coramitug [PRX004] in a phase 2 study for the treatment of patients with ATTR ...

Transthyretin amyloidosis (ATTR ... Pfizer, Novo Nordisk, Bayer and Mycardium; research grants from Alnylam Pharmaceuticals, BridgeBio Pharma, AstraZeneca and Pfizer; intermediate fellowship salary ...